STAN wa Sie ee

the most pressing problems facing the DOE/BNL Medical Survey.

In thats

I attempted to present a spectrum of solutions, ranging From purely a rese.

Mee

commitment to tota] medical care for the Marshallese affected by atomic weapons
testing in their islands.

Since that time, a number of new problems have

arisen and should be addressed in the context of the original systems analysis
format.

These new problems will not basically change the options presented in

the flow sheets but will modify some of the constraints,and require a reassessment and/or restatement of the priority of some of the objectives.
Historically,

this program has had rather a narrow focus, Looking for

radiation-related pathology, particulurly

in the thyroid, c.g., thyroid adenomas,

carcinomas, and biologic hypothyroidism, and in the hematopoietic system, @.f.,
blood dyscrasias in the study group.

Over the last year a number of new

problems have emerged that will probably require a sizeable increase in the scope
of the program.

They are:

1) New data (previously secret) has revealed that

Likiep Atoll received detectable fallout after the 1 March 1954 detonation. Mr.
Anton DeBrum, Secretary of State of the new Marshall Islands government,
designed and circulated a medical questionnaire to the residents of Likiep.

The

results of that questionnaire were delivered to the U.S. Covernnent and the U.N.

with a demand that "something" be dene to evaluate the situation on Likiep.
are currently working with an

verify Mr.

DeBrum's findings.

independent

Ff,

We

epidemiologic consulting group to

in tact, Likiep shaws a sipniffeant increase

in birth defeets or selected cancers,

then the DOE feels a full wnedical survey

of the islands in the Likicep Atetl should be undertaken.
An ancillary problem that mist be considered
of Likicp.

If Likiep shows an inereased

related patholopy,

is the peographical locatioa

incidence of possibly radiation-

then a number of atolls Tyjnug, between Likiep and the
a

Select target paragraph3